The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family - PubMed (original) (raw)

The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family

G Mosialos et al. Cell. 1995.

Free article

Abstract

The cytoplasmic C-terminus of Epstein-Barr virus (EBV) latent infection membrane protein 1 (LMP1) is essential for B lymphocyte growth transformation and is now shown to interact with a novel human protein (LMP1-associated protein 1 [LAP1]). LAP1 is homologous to a murine protein, tumor necrosis factor receptor-associated factor 2 (TRAF2), implicated in growth signaling from the p80 TNFR. A second novel protein (EBI6), induced by EBV infection, is the human homolog of a second murine TNFR-associated protein (TRAF1). LMP1 expression causes LAP1 and EBI6 to localize to LMP1 clusters in lymphoblast plasma membranes, and LMP1 coimmunoprecipitates with these proteins. LAP1 binds to the p80 TNFR, CD40, and the lymphotoxin-beta receptor, while EBI6 associates with the p80 TNFR. The interaction of LMP1 with these TNFR family-associated proteins is further evidence for their role in signaling and links LMP1-mediated transformation to signal transduction from the TNFR family.

PubMed Disclaimer

Similar articles

• The residues between the two transformation effector sites of Epstein-Barr virus latent membrane protein 1 are not critical for B-lymphocyte growth transformation.
  Izumi KM, Cahir McFarland ED, Riley EA, Rizzo D, Chen Y, Kieff E. Izumi KM, et al. J Virol. 1999 Dec;73(12):9908-16. doi: 10.1128/JVI.73.12.9908-9916.1999. J Virol. 1999. PMID: 10559303 Free PMC article.
• Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.
  Eliopoulos AG, Stack M, Dawson CW, Kaye KM, Hodgkin L, Sihota S, Rowe M, Young LS. Eliopoulos AG, et al. Oncogene. 1997 Jun 19;14(24):2899-916. doi: 10.1038/sj.onc.1201258. Oncogene. 1997. PMID: 9205097
• Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein.
  Kaye KM, Devergne O, Harada JN, Izumi KM, Yalamanchili R, Kieff E, Mosialos G. Kaye KM, et al. Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):11085-90. doi: 10.1073/pnas.93.20.11085. Proc Natl Acad Sci U S A. 1996. PMID: 8855313 Free PMC article.
• LMP1 TRAFficking activates growth and survival pathways.
  Soni V, Cahir-McFarland E, Kieff E. Soni V, et al. Adv Exp Med Biol. 2007;597:173-87. doi: 10.1007/978-0-387-70630-6_14. Adv Exp Med Biol. 2007. PMID: 17633026 Review.
• Biochemical and genetic studies of Epstein-Barr virus latent membrane protein 2.
  Longnecker R. Longnecker R. Leukemia. 1994 Apr;8 Suppl 1:S46-50. Leukemia. 1994. PMID: 8152303 Review.

Cited by

• Epstein-Barr Viruses: Their Immune Evasion Strategies and Implications for Autoimmune Diseases.
  Zhao Y, Zhang Q, Zhang B, Dai Y, Gao Y, Li C, Yu Y, Li C. Zhao Y, et al. Int J Mol Sci. 2024 Jul 26;25(15):8160. doi: 10.3390/ijms25158160. Int J Mol Sci. 2024. PMID: 39125729 Free PMC article. Review.
• Post-Transplant Lymphoproliferative Disorders.
  Dharnidharka VR, Ruzinova MB, Marks LJ. Dharnidharka VR, et al. Semin Nephrol. 2024 Jan;44(1):151503. doi: 10.1016/j.semnephrol.2024.151503. Epub 2024 Mar 22. Semin Nephrol. 2024. PMID: 38519279 Review.
• Recent Advances in Assessing the Clinical Implications of Epstein-Barr Virus Infection and Their Application to the Diagnosis and Treatment of Nasopharyngeal Carcinoma.
  Yoshizaki T, Kondo S, Dochi H, Kobayashi E, Mizokami H, Komura S, Endo K. Yoshizaki T, et al. Microorganisms. 2023 Dec 20;12(1):14. doi: 10.3390/microorganisms12010014. Microorganisms. 2023. PMID: 38276183 Free PMC article. Review.
• Nasopharyngeal carcinoma: current views on the tumor microenvironment's impact on drug resistance and clinical outcomes.
  Liu H, Tang L, Li Y, Xie W, Zhang L, Tang H, Xiao T, Yang H, Gu W, Wang H, Chen P. Liu H, et al. Mol Cancer. 2024 Jan 22;23(1):20. doi: 10.1186/s12943-023-01928-2. Mol Cancer. 2024. PMID: 38254110 Free PMC article. Review.
• Epstein-Barr virus-driven B cell lymphoma mediated by a direct LMP1-TRAF6 complex.
  Giehler F, Ostertag MS, Sommermann T, Weidl D, Sterz KR, Kutz H, Moosmann A, Feller SM, Geerlof A, Biesinger B, Popowicz GM, Kirchmair J, Kieser A. Giehler F, et al. Nat Commun. 2024 Jan 10;15(1):414. doi: 10.1038/s41467-023-44455-w. Nat Commun. 2024. PMID: 38195569 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • BioCyc
  • GlyGen glycoinformatics resource
  • Mouse Genome Informatics (MGI)

• Research Materials

  • NCI CPTC Antibody Characterization Program